Inflammation and cachexia in chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Inflammation and cachexia in chronic kidney disease.

Inflammation and cachexia in chronic kidney disease.

http://www.wikidata.org/entity/Q34616311

about

Metabolic syndrome in children with chronic kidney disease and after renal transplantation Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia?Wasting in chronic kidney disease A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α.Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.Effect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats.Systemic zinc redistribution and dyshomeostasis in cancer cachexia.Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.Neuropeptides in the pathophysiology and treatment of cachexia.Mechanisms of muscle wasting in chronic kidney disease Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the chronic renal insufficiency cohort study.Cachexia & debility diagnoses in hospitalized children and adolescents with complex chronic conditions: evidence from the Kids' Inpatient Database.The impact of inflammation on bone mass in children.Association of frailty with body composition among patients on hemodialysis Cachexia and protein-energy wasting in children with chronic kidney disease.Leptin in anorexia and cachexia syndrome.Exploring metabolic dysfunction in chronic kidney disease.CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.Inflammatory factors and exercise in chronic kidney disease.Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.Effects of dexamethasone on angiotensin II-induced changes of monolayer permeability and F-actin distribution in glomerular endothelial cells.Association of genetic variants of ghrelin, leptin and UCP2 with malnutrition inflammation syndrome and survival in end-stage renal disease patients.Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.Exercise for children with chronic kidney disease and end-stage renal disease.Nutrition in infants and very young children with chronic kidney disease.Exercise limitation following transplantation.Why does three times per week hemodialysis provide inadequate dialysis for children?Growth failure and nutrition considerations in chronic childhood wasting diseases.Physical activity, immune function and inflammation in kidney patients (the PINK study): a feasibility trial protocol.Muscle wasting in chronic kidney disease.Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.Dietary sources of energy and nutrient intake among children and adolescents with chronic kidney disease.NF-κB expression and its association with nutritional status in hemodialysis patients.Glucocorticoid-Regulated Kinase: Linking Azotemia and Muscle Wasting in CKD Transcription of the Tumor Suppressor Genes p53 and RB in Lymphocytes from Patients with Chronic Kidney Disease: Evidence of Molecular Senescence?Optimal hemodialysis prescription: do children need more than a urea dialysis dose?Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis.

P2860

Q27027049-9C72F09A-7187-42A0-9755-1A6063F17A2D Q28084066-54334793-84BC-4ED1-9554-B8B120498E65 Q30432774-BC5DF95A-3DE9-4E98-9478-F4BA645BC75A Q33901304-A6822CF7-4921-490F-AF9B-EBB33EDACE48 Q34390204-8C2F355B-B318-4885-A23C-01DD5CEE8468 Q34577095-713AC498-3CEC-4E33-87E6-74CD80C0A241 Q34697225-A6D1C51E-5214-4FFD-9996-5BE817B90E42 Q34697244-40B0428F-4C1D-40C8-8940-61E6EC9F7A04 Q34712204-F6D8C242-CBCE-4C97-BBC9-25936A9511FA Q34723810-2B738E31-F976-492B-9232-C19BA1C9E698 Q35082679-A67C0C4D-5802-4771-A799-71C4EA0B00E6 Q35157920-EB211D39-807E-435F-AA15-F9BEBE05ABF5 Q35226354-A821B9E2-A454-40ED-9254-C589E7AEA1FF Q35260720-49E6BE30-17C3-4CD7-9346-2943405F9165 Q35645564-07F159CE-0BF5-400A-AE9E-9EB5E2AAD599 Q35829778-A15D133E-7A20-4499-8562-44E6AFB61FBD Q36123347-7E775E45-3A7E-4A5A-A815-725623FDC8FA Q36514936-B29181EF-5AEA-45AB-A9CD-6F97B4822E3B Q36882794-E8B66BB5-10A9-419E-AE82-2D3D88F8F4AF Q37029157-D1F6F25D-7619-440A-9DAC-E2F6A9907C6C Q37289130-E7D1D931-E0EB-483C-B5AF-C9FBD8C97D10 Q37300041-EDFCD5C1-4884-4673-AD84-D4A4C7C3F05E Q37405600-79B4CC15-80EA-4AD4-A36A-F3A9052FA2CB Q37734762-42CDB8F3-1965-4B0B-91F0-8AA7056759A6 Q37828085-F79746BC-9113-4964-A365-F9BABBB7D96C Q37923385-D48204BD-D835-4F6C-931C-EACE67316925 Q38110753-C11526C9-24ED-4678-9071-4E6233FD4C1A Q38261465-B7D95BE6-73C3-4878-9179-3938D83D93D5 Q38265982-09AD9C07-8F91-4D83-B54A-91A740A868E5 Q38758092-B8C7DB76-40A6-4932-96DF-4A78748E255C Q38784295-6538981A-8686-4ADF-A726-1BAD7FB79DFD Q39099310-B33B5AF6-CF4B-4D63-9FD2-4A07C2B6546B Q39466056-6815F96D-992A-4154-9636-A51E6B4B07A2 Q40330814-C9234E7D-E88D-4FE5-B2EE-808A1A822F61 Q40563733-983DED7F-F0F4-421A-97D6-635C7DE9DEF7 Q42399760-68402FC7-941F-4238-9A5C-299ADE3230F3 Q42542857-F1BE1135-1A57-4BA3-A7E6-9FB9C4746992 Q42746232-10B71302-68B4-4EF3-B085-5E2537D6C20E Q44632321-17A2470B-21CD-4A70-ADDC-B3BE141224E9 Q44937064-043383A8-5037-48E2-8C3E-DCF40C28E730

P2860

Inflammation and cachexia in chronic kidney disease.

http://www.wikidata.org/entity/Q34616311

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inflammation and cachexia in chronic kidney disease.

@ast

Inflammation and cachexia in chronic kidney disease.

@en

Inflammation and cachexia in chronic kidney disease.

@nl

type

label

Inflammation and cachexia in chronic kidney disease.

@ast

Inflammation and cachexia in chronic kidney disease.

@en

Inflammation and cachexia in chronic kidney disease.

@nl

prefLabel

Inflammation and cachexia in chronic kidney disease.

@ast

Inflammation and cachexia in chronic kidney disease.

@en

Inflammation and cachexia in chronic kidney disease.

@nl

P1433

Q34616311-7C00CEFE-BBD6-4839-9964-683CB0799139

P1476

Q34616311-D74DA36B-925D-4C53-8948-9BB2FA78F31C

P2093

Q34616311-3141F8C4-270E-4065-B281-2F4C92851C79

Q34616311-424CD79F-CE5B-4DCC-85B6-B823B3B0AB66

Q34616311-CE4D7D01-B823-4EC7-B5BD-B2D68E41E24B

P2860

Q34616311-12497402-9BEE-4141-BFA5-860A16E2EEA4

Q34616311-3D858AC7-92BB-42AB-BE31-FDB4C2E59A67

Q34616311-4F15CFDD-8EB1-4A7D-8974-BC4CBE9144A4

Q34616311-9B6F274C-3B34-43CC-8FDC-44087048D6C1

Q34616311-B3A17BF8-41A9-4286-8E03-E5FE57AF2BB4

Q34616311-DEE7FFD8-A854-4442-AEE3-34B6CF646188

Q34616311-EB5B532F-3E84-4271-A92F-7C583CA343DE

P2888

Q34616311-AF9DE01A-931A-4FCD-824A-0536C0C52323

P304

Q34616311-D88E1E9A-41CA-4916-882A-479EB8EFAF87

P31

Q34616311-306BD370-9AF7-4501-B3A9-CE50F8A5122A

P356

Q34616311-6002CA42-77D7-43D9-B29B-7D2FCFFFCC03

P433

Q34616311-C8B53CE6-CB6B-4554-BD6B-3BC763779E9A

P478

Q34616311-0C66C8FB-9BA3-4FD5-9B4F-8B8161FFB2D1

P577

Q34616311-05F873F1-00D8-49AC-8ADB-BFBDAD0DD674

P5875

Q34616311-E8A7C613-DC6A-4A11-951D-74E1DBE7A9C6

P6179

Q34616311-E2B19814-85BF-4BD9-ADC9-01541D3FF6C5

P698

Q34616311-42783D03-2989-441F-9B54-72A92C767727

P356

S00467-009-1427-Z

P1433

Pediatric Nephrology

P1476

Inflammation and cachexia in chronic kidney disease.

@en

P2093

Kyung Hoon Paik

http://www.w3.org/2001/XMLSchema#string

Robert H Mak

http://www.w3.org/2001/XMLSchema#string

Wai W Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients.

New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.

Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein.

Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia.

P2888

s00467-009-1427-z

P304

711-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-009-1427-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41175235

http://www.w3.org/2001/XMLSchema#string

P6179

1019628203

http://www.w3.org/2001/XMLSchema#string

P698

20111974

http://www.w3.org/2001/XMLSchema#string